As the premier academic medical center of central Ohio, The Ohio State University and The James Cancer Center house an active hematology/oncology group featuring clinical trials, an active bone marrow transplant service, myeloproliferative neoplasms subspecialty group, pioneers in BTK inhibitor therapy, and CART therapy. This provides the Hematopathology Fellow ample opportunities to participate in the diagnosis and monitoring of the full breadth of both myeloid and lymphoid neoplasms.